Skip to content

Sotera Health SHC Gain (Loss), Foreign Currency Transaction, before Tax

Other financials

Income statement

See full
Revenue$280.0M+10.0%
Gross profit$147.1M+8.6%
Operating income$87.1M-16.2%
Net income$26.6M+301%
EPS (diluted)$0.09+280%

Balance sheet

See full
Cash & equivalents$314.1M+3.2%
Total debt$2.3B-3.2%
Total equity$622.5M+50.3%
Total assets$3.2B+4.5%

Cash flow

See full
Operating cash flow$29.4M-47.0%
CapEx$46.2M+132%
Free cash flow-$16.7M-147%

Valuation

See full
Market cap$4.51B+23.4%

Profitability

See full
Gross margin55.3%+0.1pp
Operating margin27%+0.7pp
Net margin9.9%+7.7pp
FCF margin8.1%

Returns & leverage

See full
Return on equity22.7%+16.8pp
Debt / equity3.6×-2.0×
Current ratio2.8×+0.4×

Where this comes from

Reported directly by Sotera Health in its filing.

Tagged under the XBRL concept us-gaap:ForeignCurrencyTransactionGainLossBeforeTax.

The official record: Sotera Health’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Questions, answered.

What is Sotera Health's gain (loss), foreign currency transaction, before tax?
Sotera Health (SHC) reported gain (loss), foreign currency transaction, before tax of $571K in Q1 2026.
How has Sotera Health's gain (loss), foreign currency transaction, before tax changed year-over-year?
Sotera Health's gain (loss), foreign currency transaction, before tax increased by 297.6% year-over-year, from -$289K to $571K.
What is the long-term trend for Sotera Health's gain (loss), foreign currency transaction, before tax?
Over 3 years (2021 to 2025), Sotera Health's gain (loss), foreign currency transaction, before tax has grown at a -12.4% compound annual growth rate (CAGR), from -$1.41M to -$947K.